These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 226879)

  • 41. [Lipid lowering improved? Therapeutic progress by using biological mechanisms].
    Udelhoven P
    Med Welt; 1982 Sep; 33(36):3. PubMed ID: 7132677
    [No Abstract]   [Full Text] [Related]  

  • 42. Cholesterol absorption inhibitors in the treatment of hyperlipidemia: clinical outcomes in large clinical trials.
    Kesäniemi A
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():29-30. PubMed ID: 18001318
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clofibrate therapy in hypercholesterolemia. Reports on medium-long-term movements of HDL- cholesterol by the action of clofibrate].
    Mertz DP
    Fortschr Med; 1980 Dec; 98(45):1761-6. PubMed ID: 7461569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Xanthomatosis and hyperlipoproteinemia; a review.
    Polano MK
    Dermatologica; 1974; 149(1):1-9. PubMed ID: 4372111
    [No Abstract]   [Full Text] [Related]  

  • 45. [Pravastatin increases the activity pf the LDL receptors in lymphocytes of individuals with heterozygous familial hypercholesterolemia].
    Alvarez-Sala LA; Mata P; Blázquez E; Garrido JA; Ordovás JM; Rubio MJ; de Oya M
    Rev Clin Esp; 1997 May; 197(5):317-22. PubMed ID: 9280964
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atherogenic lipoprotein particle size and concentrations and the effect of pravastatin in children with familial hypercholesterolemia.
    van der Graaf A; Rodenburg J; Vissers MN; Hutten BA; Wiegman A; Trip MD; Stroes ES; Wijburg FA; Otvos JD; Kastelein JJ
    J Pediatr; 2008 Jun; 152(6):873-8. PubMed ID: 18492534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The difficult road to cholesterol homeostasis].
    Joossens JV
    Verh K Acad Geneeskd Belg; 1984; 46(1):5-31. PubMed ID: 6331021
    [No Abstract]   [Full Text] [Related]  

  • 48. Combined effects of clofibrate and diosgenin on cholesterol metabolism in rats.
    Cayen MN; Dvornik D
    Atherosclerosis; 1978 Mar; 29(3):317-27. PubMed ID: 208586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nicotinic acid for the treatment of hyperlipoproteinemia.
    Drood JM; Zimetbaum PJ; Frishman WH
    J Clin Pharmacol; 1991 Jul; 31(7):641-50. PubMed ID: 1894760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of polyenyl phosphatidyl choline on clofibrate-induced increase in LDL cholesterol.
    Schneider J; Müller R; Buberl W; Kaffarnik H; Schubotz R; Hausmann L; Mühlfellner G; Mühlfellner O
    Eur J Clin Pharmacol; 1979 Feb; 15(1):15-9. PubMed ID: 217694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trial watch: Antisense agent reduces LDL-cholesterol levels in high-risk patients.
    Nat Rev Drug Discov; 2010 Jan; 9(1):10. PubMed ID: 20043021
    [No Abstract]   [Full Text] [Related]  

  • 52. Bezafibrate treatment in primary hypercholesterolaemia. Possibility of intermittent treatment.
    Fringes B; Riede UN; von Deimling O
    Atherosclerosis; 1982 Sep; 44(3):391-2. PubMed ID: 7150401
    [No Abstract]   [Full Text] [Related]  

  • 53. [Atherosclerosis: treatment of hereditary hypercholesterolemia].
    Kukharchuk VV
    Kardiologiia; 1990 Aug; 30(8):5-6. PubMed ID: 2255142
    [No Abstract]   [Full Text] [Related]  

  • 54. [Treatment of type II hyperlipoproteinemia--personal experiences].
    Sznajderman M
    Pol Arch Med Wewn; 1978 Feb; 59(2):153-60. PubMed ID: 205843
    [No Abstract]   [Full Text] [Related]  

  • 55. A comparison of clofibrate and its derivative methyl clofenapate.
    Craig GM
    Atherosclerosis; 1972; 15(2):265-71. PubMed ID: 4666129
    [No Abstract]   [Full Text] [Related]  

  • 56. Application of the concanavalin A precipitation technique in an evaluation of fenofibrate action on cholesterolemia in IIa and IIb hyperlipemic subjects.
    Chicaud P; Demange J; Drouin P; Debry G
    Pharmacology; 1983; 26(2):90-4. PubMed ID: 6844393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The hypocholesterolemic effect of terbufibrol and other drugs in normal and hypercholesterolemic baboons.
    Howard AN; Zschocke R; Löser R; Hofrichter G
    Atherosclerosis; 1979 Apr; 32(4):367-80. PubMed ID: 223594
    [No Abstract]   [Full Text] [Related]  

  • 58. [Cholesterol--now what?].
    Smith P
    Tidsskr Nor Laegeforen; 2001 Mar; 121(9):1022. PubMed ID: 11354872
    [No Abstract]   [Full Text] [Related]  

  • 59. Carotenoids and vitamin A: the effect of hypocholesterolemic agents on serum levels.
    Probstfield JL; Lin TL; Peters J; Hunninghake DB
    Metabolism; 1985 Jan; 34(1):88-91. PubMed ID: 3965864
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group.
    JAMA; 1973 Nov; 226(6):652-7. PubMed ID: 4356847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.